
Panelists challenge the belief that testosterone fuels prostate cancer, explain PSA on therapy and TRAVERSE BPH data, and weigh Schedule III status.
Chicago - Treatment with bacille Calmette-Guérin plus interferon-alpha-2B appearsto be effective in a salvage situation for superficial bladder cancer patientswho have failed primary BCG treatment.





